Eli Lilly’s $8 billion deal for cancer-treating upstart Loxo Oncology is a worthy wager rob_cyran
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Eli Lilly to Buy Loxo Oncology in Deal It Values at About $8 BillionEli Lilly said it is buying Loxo Oncology for $235 a share—a 68% premium from Friday’s closing price—in cash, a deal that expands the biopharmaceutical company’s oncology-treatment portfolio.
Baca lebih lajut »
Eli Lilly to buy Loxo Oncology in $8 billion cancer pushThe pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
Baca lebih lajut »
Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancerEli Lilly's $8 billion acquisition of biotech Loxo Oncology is a notably large deal for Eli Lilly, but it could be done again, its CEO said.
Baca lebih lajut »
Lilly to buy Loxo Oncology in $8 billion cancer pushEli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 bill...
Baca lebih lajut »
Eli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly said it would stop promoting Lartruvo, a relatively new cancer drug, after a study found it didn’t significantly prolong the lives of patients when used in combination with an older drug.
Baca lebih lajut »
Eli Lilly to spend about $8B on Loxo OncologyEli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and...
Baca lebih lajut »
Eli Lilly CEO: Loxo acquisition can help us treat cancer globally'This is the future of cancer treatment, we believe.' Eli Lilly CEO David Ricks said that Loxo Oncology has 'harnessed the power of emerging science' and that Lilly's acquisition of Loxo can help treat cancer globally.
Baca lebih lajut »
The inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancerEli Lilly's $8 billion bid for Loxo Oncology was negotiated during the 2018 holiday season, so as to make a big splash at a major industry conference.
Baca lebih lajut »